EP Patent

EP0169105A2 — Controlled porosity osmotic pump

Assigned to Merck and Co Inc · Expires 1986-01-22 · 40y expired

What this patent protects

(57) The instant invention is directed to an osmotic pump comprising: (a) at least one active agent surrounded by (b) a water insoluble wall, having a fluid permeability of 6.96 x 10 -18 to 6.96 x 10 -14 cm 3 sec/g and a reflection coefficient of less than 1, prepared fr…

USPTO Abstract

(57) The instant invention is directed to an osmotic pump comprising: (a) at least one active agent surrounded by (b) a water insoluble wall, having a fluid permeability of 6.96 x 10 -18 to 6.96 x 10 -14 cm 3 sec/g and a reflection coefficient of less than 1, prepared from: (i) a polymer permeable to water but impermeable to solute, and (ii) 0.1 to 60% by weight, based on the total weight of (i) and (ii), of at least one pH insensitive pore forming additive dispersed throughout said wall.

Drugs covered by this patent

Patent Metadata

Patent number
EP0169105A2
Jurisdiction
EP
Classification
Expires
1986-01-22
Drug substance claim
No
Drug product claim
No
Assignee
Merck and Co Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.